Cornell Pochily Investment Advisors, Inc. Amgen Inc Transaction History
Cornell Pochily Investment Advisors, Inc.
- $284 Million
- Q4 2024
A detailed history of Cornell Pochily Investment Advisors, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Cornell Pochily Investment Advisors, Inc. holds 7,684 shares of AMGN stock, worth $2.18 Million. This represents 0.71% of its overall portfolio holdings.
Number of Shares
7,684
Previous 7,769
1.09%
Holding current value
$2.18 Million
Previous $2.5 Million
20.02%
% of portfolio
0.71%
Previous 0.88%
Shares
29 transactions
Others Institutions Holding AMGN
# of Institutions
3,083Shares Held
401MCall Options Held
7.56MPut Options Held
7.16M-
Vanguard Group Inc Valley Forge, PA52.4MShares$14.9 Billion0.31% of portfolio
-
Black Rock Inc. New York, NY46MShares$13.1 Billion0.33% of portfolio
-
State Street Corp Boston, MA29.3MShares$8.33 Billion0.39% of portfolio
-
Morgan Stanley New York, NY14.7MShares$4.17 Billion0.35% of portfolio
-
Primecap Management CO Pasadena, CA14.3MShares$4.05 Billion3.44% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $152B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...